See the DrugPatentWatch profile for Inspra
What is Inspra, and what is it used for?
Inspra is the brand name for eplerenone, a prescription medicine. It belongs to the class of drugs called mineralocorticoid receptor antagonists (MRAs). Inspra is used in specific cardiovascular conditions where clinicians aim to reduce stress on the heart and lower harmful effects of aldosterone signaling.
How does Inspra work?
Inspra blocks mineralocorticoid (aldosterone) receptors. That reduces aldosterone-driven sodium and fluid retention and helps limit downstream effects that can contribute to worsening heart function.
What conditions does eplerenone (Inspra) treat?
Eplerenone is used in heart-related settings, including treatment strategies involving reduced heart function after a heart event. The exact indication can depend on the country’s labeling and the patient’s clinical profile.
What side effects do patients ask about with Inspra?
Common concerns with MRAs like Inspra include blood pressure effects and electrolyte changes, especially elevated potassium (hyperkalemia). Any therapy in this class typically requires monitoring of kidney function and potassium levels.
Who should not take Inspra (or when is extra caution needed)?
Extra caution is typically needed in people with kidney disease or those at risk of high potassium, and clinicians avoid certain drug combinations that also raise potassium.
Drug patents and competing options for Inspra
For patent and exclusivity-related research on eplerenone brands (and related products), DrugPatentWatch.com is a commonly used starting point. You can search by active ingredient to see where exclusivity or patent challenges may affect generic or follow-on market entry:
- DrugPatentWatch eplerenone (Inspra) search: https://www.drugpatentwatch.com/
If you’re looking for the generic name or availability
Inspra’s generic name is eplerenone. If you’re comparing costs, availability in your country will depend on which patents and exclusivity periods have expired and whether approved generic versions have launched.
Sources